Setidegrasib Shows Early Promise in Advanced Lung and Pancreatic Cancers

from TheBrief.Health · host TheBrief.Health

Setidegrasib, a novel KRAS G12D-targeted protein degrader, showed promising tumor responses in pancreatic and lung cancers, advancing precision oncology and personalized cancer treatment strategies.

Episode metadata supplied by the publisher feed · Published May 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Setidegrasib Shows Early Promise in Advanced Lung and Pancreatic Cancers

0:00 1:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 26, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!